Comparison of Record in VERITON Camera to the Anger Camera Procedure in Patients Treated by 131-iodine
NCT05713123 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77
Last updated 2024-06-20
Summary
The aim of this study is to show that the SPECT/CT whole body recording procedure lasting less than or equal to 30 minutes in a VERITON-CT™ camera, can be substituted for the classic procedure, giving at least equivalent information in searches for primary or metastatic neoplastic lesions.
Conditions
- Device
Interventions
- OTHER
-
A SPECT-CT whole body is added in VERITON-CT camera
A SPECT-CT whole body in VERITON-CT camera is added after the conventional procedure recorded in Anger camera
Sponsors & Collaborators
-
Central Hospital, Nancy, France
lead OTHER
Principal Investigators
-
Elodie CHEVALIER, MD · CHRU Nancy
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-26
- Primary Completion
- 2024-12-26
- Completion
- 2025-04-26
Countries
- France
Study Locations
More Related Trials
-
Individualized Response-adaptive Radiation Dose Prescription in HNC Based on MRI
NCT05160714 ·Status: UNKNOWN ·Phase: PHASE1
-
Radiotherapy of Head and Neck Cancer With SIB
NCT06831903 ·Status: RECRUITING
-
Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer
NCT01576796 ·Status: UNKNOWN ·Phase: PHASE2
-
Dose De-escalation to the Elective Nodal Sites in Head and Neck Cancer
NCT01812486 ·Status: COMPLETED ·Phase: PHASE3
-
Trimodal Imaging Before Radiotherapy
NCT03897166 ·Status: COMPLETED ·Phase: NA
-
Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors
NCT02960308 ·Status: COMPLETED
-
Evaluation of 3DCRT Versus IGRT and Analysis of Early Response in Head and Neck Cancer.
NCT01124409 ·Status: UNKNOWN ·Phase: PHASE3
-
Real-time Activity Monitoring to Prevent Admissions During RadioTherapy
NCT03102229 ·Status: COMPLETED ·Phase: NA
-
3D Specimen Maps for RT Planning
NCT05743569 ·Status: ACTIVE_NOT_RECRUITING
-
An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)
NCT01747512 ·Status: WITHDRAWN ·Phase: PHASE2
-
Impact of a Hypnotic Recording on Artifacts in 4D CT in the Context of Stereotactic Body Radiation Therapy for Lung Cancer
NCT07334990 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Adaptive Radiation Therapy for Head & Neck Cancer Patients
NCT01853670 ·Status: COMPLETED ·Phase: NA
-
A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System
NCT05975619 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy
NCT00608751 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Hypofractionated Radiotherapy in Breast Cancer
NCT03167359 ·Status: COMPLETED ·Phase: NA
-
Simultaneous Integrated Boost in Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic Carcinoma
NCT05733910 ·Status: RECRUITING ·Phase: NA
-
A Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck Cancer
NCT01208883 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Improved Onboard Patient Imaging
NCT06187103 ·Status: ACTIVE_NOT_RECRUITING
-
BReath Hold TecHniquEs for Radiotherapy of Esophageal Carcinoma
NCT06317272 ·Status: TERMINATED ·Phase: NA
-
Monitoring Radiobiological Effects in Thoracic Malignancy by Using Myocardial Perfusion Scan
NCT01913769 ·Status: UNKNOWN
-
Development of Real-time Image-guided Radiotherapy
NCT03524248 ·Status: TERMINATED ·Phase: NA
-
Unusual Toxicity Induced by Radiotherapy
NCT03980977 ·Status: COMPLETED ·Phase: NA
-
Ion Therapy Patient Registry
NCT03049072 ·Status: RECRUITING
-
FMISO-based Adaptive Radiotherapy for Head and Neck Cancer
NCT05348486 ·Status: RECRUITING ·Phase: NA
-
Prediction of Outcome After Chemoradiotherapy for Head and Neck Cancer Using Functional Imaging and Tumor Biology
NCT01829646 ·Status: RECRUITING ·Phase: NA